Psilocybin, ein psychotroper Wirkstoff aus dem mexikanischen RauschpilzPsilocybe mexicana Heim
The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Dennis, R. W. G., Wasson, V. P., & Wasson, R. G. (1957) · Kew Bulletin · doi:10.2307/4113701 · Cited by 122
W., G. M., Wasson, V. P., & Wasson, R. G. (1958) · Geographical Review · doi:10.2307/211720 · Cited by 65
Research works printed but not linked: 3
- R. Heim, C. R. Acad. Sci.242, 965 (1956).
- R. Heim, C. R. Acad. Sci.242, 1389 (1956);244, 695 (1957); Revue de Mycologie22, 20, 36 (1957).
- R. Heim undR. Cailleux, C. R. Acad. Sci.244, 3109 (1957);245, 597, 1761 (1957).
Cited by
Items 201–281 of 281
Schneider, S. M., & Donnelly, M. W. (2007) · Elsevier eBooks · doi:10.1016/b978-0-323-03228-5.50064-1 · Cited by 4
Clade III Synthases Add Cyclic and Linear Terpenoids to the Psilocybe Metabolome
Zschoche, N., Schober, S., Walther, K., Chadeayne, A. R., Gressler, M., Bartram, S., O'Connor, S. E., & Hoffmeister, D. (2025) · ChemBioChem · doi:10.1002/cbic.202500167 · Cited by 3
Novel qNMR Method to Quantify Psilocybin and Psilocin in Psychedelic Mushrooms
Rodríguez, L. C., Morera, G., Lupo, S., Davyt, D., Carrera, I., & Dossi, G. H. (2025) · ACS Omega · doi:10.1021/acsomega.5c07092 · Cited by 3
SCHIZOPHRENIA AND ONEIROPHRENIA*: A Clinical and Biological Note
Turner, W. J. (1964) · Transactions of the New York Academy of Sciences · doi:10.1111/j.2164-0947.1964.tb01257.x · Cited by 4
Conformational Landscape and Hydrogen Bonding Pattern of Psilocin: Computational Insights
Bhadoria, P., & Ramanathan, V. (2023) · ChemistrySelect · doi:10.1002/slct.202203994 · Cited by 3
Antipsychotic natural products
Skalicka‐Woźniak, K., & Gertsch, J. (2020) · Annual reports in medicinal chemistry · doi:10.1016/bs.armc.2020.03.004 · Cited by 4
Sueur, C. (2018) · Psychotropes · doi:10.3917/psyt.233.0125 · Cited by 6
Lewis, J. J., RITCHIE, A. P., & Petten, G. R. V. (1965) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1965.tb01787.x · Cited by 3
Zeller, M., Parent, S. D., & Schultheiss, N. (2024) · Acta Crystallographica Section E Crystallographic Communications · doi:10.1107/s2056989024004201 · Cited by 2
The Medial Prefrontal Cortex Modulates Psychedelic-like Effects of Psilocin
Zhang, M., Zhai, H., Yang, L., Li, H., & Wang, X. (2025) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.5c00324 · Cited by 4
Psilocybin Production With Genetically Modified Aspergillus nidulans Under Pressurized Conditions
Weiser, S., Jung, S., Bardl, B., Kufs, J. E., Janevska, S., Valiante, V., Hoffmeister, D., & Regestein, L. (2025) · Biotechnology and Bioengineering · doi:10.1002/bit.70137 · Cited by 3
MODERN CONCEPTS IN THE MANAGEMENT OF ANXIETY AND DEPRESSION IN THE AGED AND INFIRM
RICCITELLI, M. L. (1964) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1964.tb00357.x · Cited by 2
Occurrence of Serotonin in a Hallucinogenic Mushroom
Tyler, V. E. (1958) · Science · doi:10.1126/science.128.3326.718.a · Cited by 2
Turek, I. (2023) · Medical Writing · doi:10.56012/tsen2260 · Cited by 4
Unveiling the Psychedelic Journey: An Appraisal of Psilocybin as a Profound Antidepressant Therapy
Shah, F. I., Shehzadi, S., Akram, F., Haq, I. U., Javed, B., Sabir, S., Kazim, Y., & Ashfaq, S. (2023) · Molecular Biotechnology · doi:10.1007/s12033-023-00994-7 · Cited by 4
Li, J.-R., Chiang, K.-T., Kao, Y., Yu, C., Yang, F., Liang, C., & Hsu, T. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.10.016 · Cited by 4
The psychedelic renaissance: psilocybin, a breakthrough for treatment resistant depression?
Norman, T. R. (2025) · Exploration of neuroscience · doi:10.37349/en.2025.1006105 · Cited by 2
Do Hallucinogens Have a Role in the Treatment of Addictions? A Review of the Current Literature
Nigam, K. B., & Pandurangi, A. K. (2021) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-021-00871-x · Cited by 2
A new quantitative modification of the glyoxylic acid reaction
Rieder, H. (1960) · Clinica Chimica Acta · doi:10.1016/0009-8981(60)90062-0 · Cited by 2
Sharchaton, A., Parsha, S., Azerrad, S. P., Dekel, Y., Rabah, N., Páleníček, T., & Kurzbaum, E. (2026) · Journal of Fungi · doi:10.3390/jof12070486 · Cited by 1
Metabolomics Profiling of Edible Mushrooms: Challenges, Applications, and Future
Aruwa, C. E., S’thebe, N. W., Dweba, Y., & Saheed, S. (2025) · Reference series in phytochemistry · doi:10.1007/978-3-031-52642-8_44-1 · Cited by 3
Schäfer, T., Haun, F., Rupp, B., & Hoffmeister, D. (2025) · Angewandte Chemie · doi:10.1002/ange.202512017 · Cited by 1
Wei, L., Chen, H., & Li, Y. (2026) · Journal of Raman Spectroscopy · doi:10.1002/jrs.70178 · Cited by 1
The Criminalistics of Controlled Substances
Bono, J. P. (2007) · CRC Press eBooks · doi:10.1201/9781420054569.ch1 · Cited by 1
von Heyden, M., & Jungaberle, H. (2017) · Springer eBooks · doi:10.1007/978-3-642-55125-3_43 · Cited by 1
Snook, C. P. (2017) · Springer eBooks · doi:10.1007/978-3-319-17900-1_48 · Cited by 1
Medical Use of Cannabinoids and Psychedelic Compounds
Inserra, A., Gregorio, D. D., & Gobbi, G. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_141-1 · Cited by 1
THE SEROTONIN 5-HT 2A RECEPTOR AS AN EVOLVING NEUROTHERAPEUTIC TARGET
Bolinger, A. A., Anastasio, N. C., Cunningham, K. A., & Zhou, J. (2023) · Medicinal chemistry reviews · doi:10.1021/mc-2023-vol58.ch03 · Cited by 1
Psilocybin Therapy for Depression: A Review of Current Molecular Knowledge
Verheijen, M. C. T. (2024) · Journal of the Netherlands Society of Toxicology · doi:10.61833/jnst.2024.0002 · Cited by 2
Greene, S. L. (2025) · Comprehensive analytical chemistry · doi:10.1016/bs.coac.2024.12.002 · Cited by 1
The Cap of Liberty: Roman Slavery, Cultural Memory, and Magic Mushrooms
Omissi, A. (2016) · Folklore · doi:10.1080/0015587x.2016.1155371 · Cited by 1
Snook, C. P. (2016) · Springer eBooks · doi:10.1007/978-3-319-20790-2_48-1 · Cited by 3
Psilocybin and Magic Mushrooms: Patterns of Abuse and Consequences of Recreational Misuse
Brito-da-Costa, A. M., da Silva, D. D., Madureira-Carvalho, Á., & Dinis‐Oliveira, R. J. (2022) · Springer eBooks · doi:10.1007/978-3-030-92392-1_130 · Cited by 2
Saxton, J. E. (1965) · The Alkaloids. Chemistry and biology/The alkaloids. Chemistry and biology · doi:10.1016/s1876-0813(08)60040-8 · Cited by 2
Riconoscimento e Dosamento della Psilocibina
Fiussello, N. (1969) · Mycopathologia · doi:10.1007/bf02052798 · Cited by 1
Indole Hallucinogens Derived from Tryptophan
Hoffer, A., & Osmond, H. (1967) · Elsevier eBooks · doi:10.1016/b978-1-4832-3296-6.50008-2 · Cited by 1
Manevski, N. (2013) · Työväentutkimus Vuosikirja · Cited by 1
Involvement of 5-HT2A Receptor in the Regulation of Hippocampal-Dependent Learning and Neurogenesis
Catlow, B. J. (2008) · Digital Commons - University of South Florida (University of South Florida)
Clardy, J., & Fischbach, M. A. (2008) · Wiley Encyclopedia of Chemical Biology · doi:10.1002/9780470048672.wecb377
THE EFFECT OF 4‐HYDROXYINDOLES ON THE METABOLISM OF 5‐HYDROXYTRYPTAMINE (SEROTONIN) *
Wiseman‐Distler, M. H., & Sourkes, T. L. (1962) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1962.tb50109.x
Disposition of a Series of Tetrahydrocarbazoles
Edelson, J. C., & Benziger, D. P. (1980) · Drug Metabolism Reviews · doi:10.3109/03602538008994027
Thin-layer chromatography in the analysis of narcotic and strongly acting substances (a review)
Дегтерев, Е. В., Gaevskii, A. V., & Zenkova, E. A. (1998) · Pharmaceutical Chemistry Journal · doi:10.1007/bf02465780
Hallucinogens, CNS Stimulants, And Cannabis
Shulgin, A. T. (2019) · CRC Press eBooks · doi:10.1201/9780429260629-16
Geschwinde, T. (2003) · Springer eBooks · doi:10.1007/978-3-662-09677-2_2
Geschwinde, T. (2018) · Springer eBooks · doi:10.1007/978-3-662-56275-8_1
von Heyden, M., & Jungaberle, H. (2017) · Springer eBooks · doi:10.1007/978-3-642-55214-4_43-1 · Cited by 1
Geschwinde, T. (2012) · Springer eBooks · doi:10.1007/978-3-642-30163-6_1
(2007) · Springer eBooks · doi:10.1007/978-3-540-72045-4_2
Psilocybe mexicana R. Heim – Mexikanischer Kahlkopf
Kuhn, A., & Melzig, M. F. (2022) · Zeitschrift für Phytotherapie · doi:10.1055/a-1540-9907
Bono, J. P. (2006) · CRC Press eBooks · doi:10.1201/9781420003468.ch1
Bircher, R. P. (1959) · Angiology · doi:10.1177/000331975901000111
Conformational Analysis of Psilocybin: A Computational ApproachPreprint
Bhadoria, P., Tripathi, M. K., & Ramanathan, V. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4098712
Unravelling a New Conformer of Psilocin Through Computational MethodsPreprint
Bhadoria, P., & Ramanathan, V. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4162669
Winter, G. (2022) · Journal of Prescribing Practice · doi:10.12968/jprp.2022.4.8.340
Klassieke psychedelica als behandeling voor depressie: waar staan we vandaag?
Slechten, F., & Hert, M. D. H. M. D. (2022) · Tijdschrift voor Geneeskunde · doi:10.47671/tvg.78.22.075
Italian psychedelic therapies of the past century: An historical overview
D’Arienzo, A., & Samorini, G. (2023) · Drug Science Policy and Law · doi:10.1177/20503245231179687 · Cited by 3
The remarkable reimagining of psilocybin
Filer, C. N. (2023) · Natural Product Research · doi:10.1080/14786419.2023.2272285
Leiqi, L. I. U., Chen, J.-Z., Fu, W., & Tang, C.-Y. (2023) · Chinese Journal of Chromatography · doi:10.3724/sp.j.1123.2023.07013
Corrigendum to: Introduction to the chemistry and pharmacology of psychedelic drugs
Walker, S. R., Pullella, G. A., Piggott, M., & Duggan, P. J. (2024) · Australian Journal of Chemistry · doi:10.1071/ch23050_co · Cited by 3
Medical Use of Cannabinoids and Psychedelic Compounds
Inserra, A., Gregorio, D. D., & Gobbi, G. (2023) · Springer eBooks · doi:10.1007/978-3-030-42825-9_141-2
Zeifman, R. J. (2024) · doi:10.32920/26052859.v1 · Cited by 1
Medical Use of Cannabinoids and Psychedelic Compounds
Inserra, A., Gregorio, D. D., & Gobbi, G. (2024) · Springer eBooks · doi:10.1007/978-3-030-51366-5_141 · Cited by 1
Letzte Geheimnisse des Roten Keulenkopfs und seiner Inhaltsstoffe werden ans Licht gebracht
Petersen, F. (2024) · Springer eBooks · doi:10.1007/978-3-662-69508-1_10
Furnell, M., & Gordon, W. V. (2025) · IntechOpen eBooks · doi:10.5772/intechopen.1008802 · Cited by 4
Last secrets of ergot and its ingredients are revealed
Petersen, F. (2025) · Springer eBooks · doi:10.1007/978-3-662-69811-2_10
Metabolomics Profiling of Edible Mushrooms: Challenges, Applications, and Future
Aruwa, C. E., S’thebe, N. W., Dweba, Y., & Saheed, S. (2025) · Reference series in phytochemistry · doi:10.1007/978-3-031-80050-4_44 · Cited by 2
Zhang, X., Liu, D.-N., Miao, Q.-S., Cai, X., Zong, L.-X., Hou, Y.-K., & Xiong, J. (2025) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2025.174099
Efficacy and Safety of Psychoactive Tryptamines in Addiction: A Systematic Review
van der Meer, P. B., Schukking, N., Dik, M., van Reemst, A., Fuentes, J. J., Kaptein, A. A., Schoones, J. W., Verboeket, S. O., de Waal, M. M., Goudriaan, A. E., et al. (2025) · Psychedelic Medicine · doi:10.1177/28314425251364182
Additional file 3 of Bifurcate evolution of quinone synthetases in basidiomycetes
Seibold, P. S., Lawrinowitz, S., Raztsou, I., Gressler, M., Arndt, H.-D., Stallforth, P., & Hoffmeister, D. (2024) · Figshare · doi:10.6084/m9.figshare.26601247
Additional file 1 of Bifurcate evolution of quinone synthetases in basidiomycetes
Seibold, P. S., Lawrinowitz, S., Raztsou, I., Gressler, M., Arndt, H.-D., Stallforth, P., & Hoffmeister, D. (2024) · Figshare · doi:10.6084/m9.figshare.26601241
Additional file 2 of Bifurcate evolution of quinone synthetases in basidiomycetes
Seibold, P. S., Lawrinowitz, S., Raztsou, I., Gressler, M., Arndt, H.-D., Stallforth, P., & Hoffmeister, D. (2024) · Figshare · doi:10.6084/m9.figshare.26601244
Seibold, P. S., Dörner, S., Fricke, J., Schäfer, T., Beemelmanns, C., & Hoffmeister, D. (2024) · Figshare · doi:10.6084/m9.figshare.25698245
Synthesis and Characterization of Psilocybin Metabolites and Deuterated Analogs
Williamson, S. E., Burkhartzmeyer, E. K., Faley, M. T., Ohana, R. F., Guzei, I. A., Valley, M., Cali, J. J., & Sherwood, A. M. (2026) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5c00879 · Cited by 1
Meshkat, S., Jha, M. K., & Bhat, V. (2026) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20250043
Chemical Constituents of Psilocybe Sensu Stricto Mushrooms. A 1958 – 2025 Comprehensive Review
Tabal-Robles, A. R., Torres-Valencia, J. M., Romero-Bautista, L., González-Trujano, M. E., Guzmán‐Dávalos, L., Ramírez-Cruz, V., & Rojas‐Lima, S. (2026) · Journal of the Mexican Chemical Society · doi:10.29356/jmcs.v70i1.2551
O'Shea, A., Mason, N. L., Briedé, J. J., Schreiber, R., Verheijen, M. C. T., Krauskopf, J., & Ramaekers, J. G. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.04.742737
O'Shea, A., Mason, N. L., Schreiber, R., Verheijen, M. C. T., Ramaekers, J. G., Briedé, J. J., & Krauskopf, J. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.08.04.742716
Civardi, S. C., Besana, F., Durbano, F., Toscano, M. O. M., Raffone, F., Dell’Osso, B. M., & Olivola, M. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1858319
Magic pathways: the genes and enzymes of psilocybin biosynthesis
Worbs, J., Schäfer, T., Seibold, P. S., Blei, F., Werten, S., Rupp, B., & Hoffmeister, D. (2026) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.00117-25
Biogenic Amines in Mental Illness
Brune, G. G. (1965) · International review of neurobiology · doi:10.1016/s0074-7742(08)60758-8
Metadata
- Authors
- Hofmann, A., Heim, R., Brack, A., & Kobel, H.
- Affiliations
- Muséum national d'Histoire naturelle (FR)
- Venue
- Experientia
- Published
- 1958-03
- Volume
- 14
- Issue
- 3
- Pages
- 107-109
- ISSN
- 1420-682X (ISSN-L)
- 0014-4754
- 1420-9071
- OpenAlex
- W2398867243
- Cited by
- 282
- References
- 2
- Citations by year
- 2026: 9 · 2025: 27 · 2024: 31 · 2023: 23 · 2022: 22 · 2021: 11 · 2020: 14 · 2019: 9 · 2018: 7 · 2017: 6 · 2016: 8 · 2015: 1 · 2014: 1 · 2013: 4 · 2012: 2
- FWCI
- 31.17
- Type
- journal article
- Language
- de
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Cellular and Molecular Life Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Alkaloids: synthesis and pharmacology
- Keywords
- psilocybin, psilocin, Psilocybe mexicana, hallucinogens, psychotropic drugs, indole alkaloids, phosphorus compounds, natural product isolation
- MeSH terms
- Agaricales, Hallucinations, Indoles, Psilocybin, Psychotropic Drugs, Vegetables
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.